Stevenage Bioscience Catalyst names Forsyth CEO

U.K. biotech incubator Stevenage Bioscience Catalyst (Stevenage, U.K.) hired Sally Ann Forsyth as CEO, effective March 2018. She succeeds interim CEO Miranda Knaggs. Forsyth has been CEO of Norwich Research Park since 2013.

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), the U.K. government and the Wellcome Trust founded Stevenage Bioscience in 2012 to provide small- and mid-sized companies access to translational R&D facilities, equipment and expertise normally beyond their reach. The incubator is located at GSK's Stevenage R&D site...